|
Guangdong Xianqiang Pharmaceutical Co. , Ltd
|
Chemical name: 1 - cyclopropyl - 7 - [(S, S) - 2, 8 - dinitrogen mixed double loop [4.3.0] nonane - 8 - base] - 6 - fluoro - 8 - methoxy - 1, 4-2-4 - hydrogen oxygen generation - 3 - quinoline carboxylic acid hydrochloride chemical abstract (CAS) number: 186826-86-8 formula: C21H24FN3O4 · HCl molecular weight: 437.9 the quality of the products: sex: yellow crystalline powder indications: treatment of sensitive bacterial conjunctivitis caused by microorganisms |
Send Inquiry
|
|
Hubei Xingjiu Pharmaceutical Co., Ltd.
|
The company is a professional pharmaceutical intermediate, API production and sales of enterprises, the main products are gatifloxacin series, levofloxacin series, sarafloxacin, praziquantel, gatifloxacin, gatifloxacin, oxyfluorocarboxylic acid, etc.
The company has domestic advanced production technology and modern production facilities, perfect testing equipment and scientific research and development talents. The production management team has 10 years of industry experience to ensure product quality and production stability, and has good cooperation and development prospects.
Hubei Xingjiu Pharmaceutical Co., Ltd. is located at No. 88 Hexi Avenue, Xisai mountain area, Huangshi City, Hubei Province. The company has four departments including production department, technology department, finance department and safety and environmental protection department. It has 4 technical backbones, more than 20 production operation backbones and more than 40 employees.
Hubei Xingjiu Pharmaceutical Co., Ltd. adheres to the business tenet of "survival by quality and development by reputation". It is sincere, innovative and keeps pace with the times. It is enthusiastic to join hands with all parties to create a bright future for the pharmaceutical industry. |
Send Inquiry
|
Pharma Sources Insight June 2024: Globalization on the Go
